Agree with you here and I want to see the data ? These PRs
Agree with you here and I want to see the data ? These PRs are nice but I want to see the actual data even though it might be hard for your average joe to decipher.
These PRs seem too good to be true especially the TNBC PR. Not saying it isn’t but I’d like to see more data also BTD should be a breeze even with the small amount of people injected. A robust phase 3 with a big group of people will tell us how effective Leronlimab really is for TNBC.
Until then we need more information. I’m not sure what to make of these two PRs. December will be nice because I’m interested in all the NASH results.
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Aspo Plc's Half-Year Financial Report Overview Aspo Plc's financial performance for the first six months of 2025 reflects a commendable effort in maintaining profitability despite a challenging market landscape. The half-year financial report outlines key metrics, strategies, and future guidance that position the company favorably for sustained growth and profitability...
Continue Reading
Recognizing Innovation Among Fastest-Growing Businesses The Initiative for a Competitive Inner City (ICIC) proudly honors the impressive winners of the 2024 Inner City 100 (IC100) awards, which recognize businesses in under-resourced communities excelling in growth and innovation. These awards have been celebrating economic revitalization and creativity among companies...
Continue Reading
Pikmykid Enhances School Safety with Visitu Acquisition Pikmykid, a leading school safety platform, has recently made waves in the educational sector by acquiring Visitu, a pioneering visitor management system. This strategic move is designed to bolster Pikmykid's competencies in managing school visitors while ensuring safer educational environments for students and staff...
Continue Reading
BizClik Launches 2026 Sustainability Portfolio with Key Insights BizClik has introduced its 2026 Sustainability portfolio, featuring novel insights and ideas from industry frontrunners. This edition includes key contributions from organizations like Novartis, BW LPG, Savills, and Amazon. Readers can expect a deep dive into pressing sustainability themes, including...
Continue Reading
Dr. Timothy A. Schaub Joins Luskin Orthopaedic Institute The Luskin Orthopaedic Institute for Children is thrilled to announce that Dr. Timothy A. Schaub, M.D., F.A.C.S., MBA has been appointed as the Head of the Hand and Microsurgery Center. With an extensive background in pediatric hand and microsurgical care, Dr. Schaub is set to bolster the institute's commitment to...
Continue Reading
